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Introduction
The extracellular signal-regulated kinase (ERK) cascade con-
sists of the kinases Ras-activated factor (RAF), MEK (MAPK 
and ERK kinase), and ERK. They are coupled to a great variety 
of upstream activators and downstream effectors that regu-
late proliferation, differentiation, and survival in multicellular 
organisms. Mammalian cells contain three members of the RAF 
family (Raf-1, B-Raf, and A-Raf), two different MEK proteins 
(MEK1 and MEK2), and two ERK proteins (ERK1 and ERK2). 
These kinase isoforms appear very similar with regard to their 
structural and biochemical properties and, thus, do not reveal 
how the ERK cascade acquires signaling specifi  city to execute 
context-specifi  c physiological functions (Kolch, 2000).
Signaling specifi  city could be mediated by scaffold and 
adaptor proteins that trigger the formation of specifi  c signaling 
complexes at different subcellular locations (Morrison and 
  Davis, 2003; Teis and Huber, 2003). Two scaffold proteins are 
known to facilitate ERK activation in mammalian cells: the 
  kinase suppressor of Ras 1 (KSR1) and MEK1 partner (MP1). 
KSR1 was identifi  ed as a positive modulator of Ras/MAPK 
  signaling (Kornfeld et al., 1995; Therrien et al., 1995). Upon EGF 
stimulation, KSR1 is recruited to the plasma membrane, where 
it enhances MEK and ERK activation (Muller et al., 2001). 
MP1 was identifi  ed in a yeast two-hybrid screen as a specifi  c 
binding partner of MEK1 (Schaeffer et al., 1998). MP1 is re-
cruited to late endosomes by the adaptor protein p14 (Teis et al., 
2002). MP1 and p14 are structurally almost identical and form 
a very stable heterodimeric complex (Kurzbauer et al., 2004) 
that is required for ERK activation on endosomes (Teis et al., 
2002; Pullikuth et al., 2005). However, the biological signifi  -
cance of p14–MP1-facilitated ERK signaling was not known, 
and it was unclear whether KSR and the p14–MP1 complex 
would function in a redundant manner.
In this study, we show that the p14–MP1-MEK1 complex 
is specifi  cally required to regulate endosomal traffi  c and cellular 
proliferation. Conditional gene targeting of p14 in mice re-
veals its essential function during early embryogenesis and skin 
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T
he extracellular signal-regulated kinase (ERK) cas-
cade regulates proliferation, differentiation, and 
survival in multicellular organisms. Scaffold pro-
teins regulate intracellular signaling by providing criti-
cal spatial and temporal speciﬁ  city. The scaffold protein 
MEK1 (mitogen-activated protein kinase and ERK kinase 1) 
partner (MP1) is localized to late endosomes by the adap-
tor protein p14. Using conditional gene disruption of p14 
in mice, we now demonstrate that the p14–MP1-MEK1 
signaling complex regulates late endosomal trafﬁ  c and 
cellular proliferation. This function its essential for early 
embryogenesis and during tissue homeostasis, as revealed 
by epidermis-speciﬁ  c deletion of p14. These ﬁ  ndings show 
that endosomal p14–MP1-MEK1 signaling has a speciﬁ  c 
and essential function in vivo and, therefore, indicate that 
regulation of late endosomal trafﬁ  c by extracellular sig-
nals is required to maintain tissue homeostasis.
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development. These fi  ndings demonstrate a crucial function 
of the p14–MP1-MEK1 signaling complex in the regulation of 
tissue homeostasis.
Results and discussion
p14 is required for early 
embryonic development
We investigated the biological function of the endosomal adap-
tor protein p14 by generating mice that carry a fl  oxed p14 allele. 
The single mouse p14 gene (geneID 83409) is located on chro-
mosome 3 and is ubiquitously expressed (Wunderlich et al., 
2001). Exons 1–4 of p14 were fl  anked by loxP sites to create 
a conditional allele (Fig. S1, A–C; available at http://www.jcb.
org/cgi/content/full/jcb.200607025/DC1).
To determine whether p14 was essential for mouse 
 development,  heterozygous  p14
−/+ mice were intercrossed. 
No homozygous p14
−/− mice were identifi  ed in a total of >200 
offspring (Table I). Instead, p14
−/+ mice were born at a 2:1 ratio 
over their wild-type (wt) littermates, which was a clear indica-
tion of embryonic lethality. Embryos from p14
−/+ intercrosses 
were analyzed at different embryonic stages. No phenotypic ab-
normalities could be detected at embryonic day (E) 6.5. At E8.5, 
 25% of the embryos (n = 50) were grossly growth retarded 
with severe developmental defects and were homozygous 
  mutants (Fig. 1 A). By E10.5, no p14
−/− embryos were detected 
(n = 70; Table I). To assess whether the death of p14
−/− embryos 
was caused by placental defects, we used Mox2Cre (MORE) 
mice to delete p14 specifi  cally in the epiblast (Tallquist and 
  Soriano, 2000). Epiblast-restricted p14 deletion also caused 
  embryonic lethality before E10.5 (n = 86; Table I). These data 
suggested that the embryonic lethality of p14
−/− mice was not 
caused by placental defects but was the result of defects in the 
developing embryo.
Figure 1.  p14 is an essential gene required for 
embryonic development and endosomal ERK 
activation. (A) Homozygous p14
−/− embryos 
die around gastrulation. Representative p14
−/− 
and p14
−/+ E8 embryos are shown. (B) p14
f/− 
and  p14
−/− MEFs were infected with either 
control retrovirus (IRES-GFP) or p14 retrovirus 
(p14-IRES-GFP). p14
f/−;IRES-GFP, p14
−/−;IRES-
GFP,  p14
−/−;p14-IRES-GFP, and p14
f/−;p14-
IRES-GFP cell lysates were separated by 
SDS-PAGE, analyzed by Western blotting, and 
probed with the indicated antibodies. The as-
terisk marks the background band of the p14 
antibody. (C) p14
f/− and p14
−/− MEFs were 
infected with myc-MP1 retrovirus. myc-MP1 
(green) colocalizes with LAMP1 (red) in p14
f/− 
(top) and mislocalizes to the cytoplasm in 
p14
−/− MEFs (middle). p14
−/− MEFs were in-
fected with p14-IRES-GFP retrovirus (green), 
transfected with myc-MP1 (red), and analyzed 
by immunoﬂ  uorescence microscopy using anti-
myc antibodies. (bottom) (D) p14
f/− and 
p14
−/− MEFs were starved overnight and stim-
ulated with 100 ng/ml EGF for the indicated 
times. Cell lysates were separated by SDS-
PAGE, analyzed by Western blotting, and 
probed with the indicated antibodies. Bars (A), 
300 μm; (C), 10 μm. 
Table I. Offspring analysis of p14
−/− mice
Age of crosses p14
+/+ p14
−/+ p14
−/− p14
f/− p14
f/+
p14
−/+ × p14
−/+
 E6.5 (n = 29) 6 15 8 ND ND
 E8.5 (n = 50) 13 25 12 ND ND
 E10.5 (n = 70) 19 51 0 ND ND
 PN21 (n = 210) 70 140 0 ND ND
p14
−/f × p14
−/+;MORE
 E10.5 (n = 30) ND 13 0 7 10
 PN21 (n = 56) 0 20 0 17 19
p14
−/+ intercrosses were analyzed at different developmental stages. Before E6.5, no phenotypic abnormalities of the embryos could be detected. Upon E10.5, no 
p14
−/− embryos could be detected. The epiblast-restricted deletion of p14 caused the embryonic lethality of p14
−/− mice resulting from p14
−/f × p14
−/+;MORE 
crosses. The numbers of embryos at the indicated developmental stages are given. PN, postnatal.ENDOSOMAL SCAFFOLD ADAPTOR REGULATES PROLIFERATION • TEIS ET AL. 863
The p14–MP1-MEK1 signaling complex 
regulates late endosomal trafﬁ  c
Next, we generated immortalized p14
−/− mouse embryonic 
 fi broblasts (MEFs) to determine the cellular function of p14. 
E1A-immortalized p14
f/− MEFs were infected with an adenovirus-
expressing Cre. These MEFs (p14
−/− MEFs) were devoid of 
p14 protein (Fig. 1 B) and mRNA (not depicted). Interestingly, 
the protein levels of the p14 interaction partner MP1 were also 
considerably reduced in the absence of p14, whereas protein 
levels of ERK1/2 were not affected (Fig. 1 B).
Ectopically expressed myc-MP1 localized to late endo-
somes in p14
f/− MEFs, whereas myc-MP1 mislocalized to 
the cytoplasm in p14
−/− MEFs (Fig. 1 C). Reexpression of 
p14 restored MP1 protein levels (Fig. 1 B, third lane) and 
its endosomal localization (Fig. 1 C). Thus, p14 is essential 
to recruit MP1 to late endosomes, which, in turn, is required 
for efficient and sustained EGF-induced MEK and ERK 
  signaling (Fig. 1 D).
The p14–MP1 heterodimer interacts with MEK1 (Schaeffer 
et al., 1998; Teis et al., 2002; Pullikuth et al., 2005). Because 
MEK1 has been implicated in regulating endosomal dynamics 
and Golgi disassembly during mitosis (Acharya et al., 1998; 
Pelkmans et al., 2005), we next asked whether the p14–MP1-
MEK1 complex regulates endosomal transport.
The steady-state localization of early endosomes (EEA1) 
was not altered in p14
−/− and Mek1
−/− MEFs (Fig. 2 A). 
  However, late endosomes, multivesicular bodies (MVBs; lyso-
bisphosphatidic acid [LBPA]), and lysosomes (LAMP1) were 
displaced to the cell periphery (Fig. 2 A, arrows). Reexpression 
of p14 restored the perinuclear localization of late endosomes 
(Fig. 2 C). A mutant p14caax, which resides at the plasma 
  membrane (Teis et al., 2002), did not restore proper endosomal 
Figure 2.  p14 is required for late endosomal positioning and EGFR transport. (A) p14
f/− and p14
−/− as well as MEK1
−/− and KSR1
−/− MEFs were sub-
jected to immunoﬂ  uorescence analysis with the indicated antibodies. EEA1, LAMP1, and LBPA are shown in red, and nuclei are stained with DAPI (blue). 
(B) Distribution analysis of LAMP1-positive endosomes in p14
f/− and p14
−/− MEK1
+/+ and MEK1
−/− MEFs. The distance distribution of LAMP1-positive 
  endosomes to the nucleus is shown. (C) p14
f/− were infected with control retrovirus (IRES-GFP), and p14
−/− MEFs were infected with retrovirus-expressing 
p14 (p14;IRES-GFP) or p14caax (p14caax;IRES-GFP) and subjected to immunoﬂ  uorescence analysis. LAMP1 is shown in red, and GFP expression from dif-
ferent IRES-GFP retroviruses indicates p14 or p14caax expression. (D) p14
f/−, p14
−/−, MEK1
−/−, and KSR1
−/− MEFs were starved overnight and stimu-
lated with 100 ng/ml of ﬂ  uorescently labeled EGF. Cells were ﬁ  xed at the indicated times and subjected to confocal immunoﬂ  uorescence analysis with the 
indicated antibodies. EGF is shown in green, and EEA1 and LAMP1 are shown in red. Colocalization of EGF with either EEA1 or LAMP1 is shown in yellow 
(arrows). (E) p14
f/− and p14
−/− MEFs were starved overnight and stimulated with 100 ng/ml EGF for the indicated times. Cell lysates were separated by 
SDS-PAGE, analyzed by Western blotting, and probed with the indicated antibodies. One representative EGFR immunoblot is shown. The EGFR degrada-
tion was analyzed in three independent experiments, and EGFR protein levels were normalized to total ERK protein levels. The graph shows the mean EGFR 
degradation in p14
f/− and p14
−/− MEFs. Error bars represent SD. Bars, 10 μm.JCB • VOLUME 175 • NUMBER 6 • 2006  864
  localization (Fig. 2 C). This fi  nding demonstrates a crucial role of 
p14 in the regulation of late endosomes. To investigate whether 
the positioning of late endosomes requires p14–MP1-MEK1 
signaling, we determined the localization of MVBs and lyso-
somes in MEFs in which MEK1 was deleted (Mek1
−/− MEFs; 
Fig. 2 A). MVBs and lysosomes were displaced to the cell pe-
riphery in Mek1
−/− MEFs (Fig. 2 A, arrows), which is reminis-
cent of their mislocalization in p14
−/− MEFs. Early as well as 
late endosomes and lysosomes were not affected in KSR1
−/− 
MEFs (Fig. 2 A).
An endosome distribution analysis was performed to de-
termine the position of late endosomes and lysosomes (LAMP1) 
relative to the nucleus (Fig. 2 B and Fig. S2 B, available 
at http://www.jcb.org/cgi/content/full/jcb.200607025/DC1). In 
p14
f/− and Mek1
+/+ MEFs,  80% of late endosomes and lyso-
somes were located in a perinuclear region (within 20 μm of the 
nucleus), and 20% were >20 μm away. Notably,  40% of all 
late endosomes and lysosomes in the p14
−/− and Mek1
−/− MEFs 
were >20 μm away from the nucleus. However, the total num-
ber of late endosomes and lysosomes was not changed (Fig. 2 B 
and Fig. S2 B). These fi  ndings indicate that the p14–MP1-
MEK1 complex but not KSR1 is required to regulate the distri-
bution of late endosomes.
To determine whether the p14–MP1-MEK1 signaling 
complex is required for effi  cient transport from early endosomes 
to late endosomes and lysosomes, we used different endocytic 
cargos. The p14–MP1-MEK1 complex does not regulate the 
uptake or endosomal traffi  c of transferrin or dextran (Fig. S2 A). 
EGF-induced endocytosis of the EGF receptor (EGFR) into 
early endosomes was not affected (Fig. 2 D, 10 min). In p14
f/− 
and KSR1
−/− MEFs, EGF colocalized with LAMP1-positive 
late endosomes (Fig. 2 D, 30 min; arrows). However, no colo-
calization of EGF with LAMP1 was detected in p14
−/− and 
Mek1
−/− MEFs (Fig. 2 D, 30 min). To further assess the defect 
in endocytic EGFR traffi  c, we used quantitative immunoblot 
analysis of EGFR degradation (Fig. 2 E and Fig. S2 C). 60 min 
after EGF stimulation, >60% of total EGFR was degraded in 
the p14
f/− MEF, whereas only 30% of total EGFR was degraded 
in the p14
−/− MEF (Fig. 2 E and Fig. S2 B). Together, these 
fi  ndings show that late endosomal sorting of activated cell 
  surface receptors is a specifi  c function of the p14–MP1-MEK1 
signaling complex.
p14 is required for epidermal development
We next addressed how altered late endocytic traffi  c and re-
duced ERK signaling would affect tissue homeostasis. Because 
EGFR and ERK signaling are critical regulators of epidermal 
proliferation and differentiation, we performed the conditional 
deletion of p14 in the epidermis. p14
f/f were crossed with K5-
Cre2 transgenic mice (Tarutani et al., 1997) and bred further 
to generate p14
f/f;K5-Cre2 (p14
∆ep) animals. PCR analysis from 
epidermal DNA and Western blot analysis from epidermal ly-
sates demonstrated that p14 was specifi  cally deleted in the epi-
dermis but not in the dermis (Fig. 3 F and Fig. S1, D and E). 
p14
∆ep mice were born alive but died shortly after birth. E18.5 
embryos were alive but displayed dramatic skin defects. p14
∆ep 
skin appeared erythemic and moist as compared with p14
∆ep/+ 
control littermates (Fig. 3 A). The p14
∆ep epidermis consisted 
of only a few (four or less) cell layers, and nucleated cells were 
frequently found in the uppermost cell layer (Fig. 3 A, arrow). 
Figure 3.  The p14–MP1 complex is required for epidermal development and regulates ERK signaling and EGFR degradation. (A) Representative phenotype 
of E18.5 p14
∆ep/+ and p14
∆ep embryos. Semithin sections of E18.5 p14
∆ep and p14
∆ep/+ skin were stained with Toluidine blue. The p14
∆ep/+ skin consists 
of stratum corneum (SC), granular layers (GL), spinous layers (SL), and the basal layer (BL). p14
∆ep lacks the stratum corneum and granular layer. The arrow 
indicates a nucleated cell in the uppermost layer of p14
∆ep skin. (B) E18.5 p14
∆ep and p14
∆ep/+ embryos were subjected to an epidermal barrier assay. 
X-Gal fully penetrated the p14
∆ep epidermis of embryos. (C–E) Frozen skin sections from E18.5 p14
∆ep and p14
∆ep/+ embryos were analyzed by confocal 
laser-scanning immunoﬂ  uorescence microscopy. β4-Integrin is shown in red. Bars, 10 μm. (C) pERK1/2 (green) is strongly reduced in the basal compart-
ment of p14
∆ep epidermis. Note the unspeciﬁ  c background staining in the stratum corneum in panel p14
∆ep/+. (D) EGFR (green) is present at the plasma 
membrane of suprabasal keratinocytes in the p14
∆ep epidermis. Insets show magniﬁ  cations of boxed areas. (E) Keratin 6 is shown in green and is normally 
conﬁ  ned to the innermost cell layer of the outer root sheath. (F) Equal protein amounts of epidermal lysates from E18.5 p14
∆ep and p14
∆ep/+ embryos were 
analyzed by Western blotting with the indicated antibodies. Asterisks indicate the background bands of the p14 and MP1 antibodies.ENDOSOMAL SCAFFOLD ADAPTOR REGULATES PROLIFERATION • TEIS ET AL. 865
The stratum corneum and granular layers were not defi  ned. This 
indicated compromised terminal differentiation, which resulted 
in a fatal skin barrier defect (Fig. 3 B) and rapid dehydration, 
fi  nally causing the perinatal death of the p14
∆ep mice. These 
fi  ndings demonstrated an essential function of p14 in the devel-
opment of the epidermis.
The p14–MP1-MEK1 complex is required 
for ERK signaling and regulates EGFR 
degradation during epidermal development
Immunofl  uorescence (Fig. 3 C) and Western blot analysis from 
epidermal lysates (Fig. 3 F) demonstrated that p14 is specifi  -
cally required for MEK and ERK activation in the epidermis but 
does not affect the p38 or JNK pathway. Because p14–MP1-
MEK1 signaling is required to regulate transport of the EGFR 
to late endosomes, we next asked whether the fatal failure of 
epidermal development is caused by aberrant EGFR traffi  c. 
Consistent with previously published results (Sibilia and Wagner, 
1995), the EGFR was expressed in the basal cell layer of p14
∆ep/+ 
epidermis (Fig. 3 D, inset). However, in p14
∆ep epidermis, 
EGFR expression was not restricted to the basal cell layer and 
extended frequently into suprabasal cell layers (Fig. 3 D, inset), 
indicating an impaired degradation of EGFR. The failure to 
down-regulate the EGFR in the suprabasal cell layers resulted 
in unscheduled and strong suprabasal keratin 6 expression (Fig. 
3 E). Keratin 6 expression is known to be induced by suprabasal 
EGFR expression (Jiang et al., 1993). The expression of kera-
tins 14, 10, and 1 was only mildly affected (Fig. S1 G). Thus, 
impairment of late endosomal transport and subsequent supra-
basal accumulation of the EGFR might result in unscheduled 
keratin 6 expression, which caused the disastrous failure of the 
epidermal development of p14
∆ep animals.
The p14–MP1 complex regulates 
cellular proliferation
Induction of keratin 6 indicates a pathological status of the epi-
dermis and is frequently associated with hyperproliferation. 
However, the p14
∆ep epidermis was much thinner compared 
with the p14
∆ep/+ epidermis (Fig. 3 A). Cell death was not in-
creased as monitored by TUNEL analysis and activated caspase-3 
immunofl  uorescence staining (Fig. S1 H). Therefore, we in-
vestigated whether cell cycle progression was affected in the 
p14
∆ep epidermis.
To detect keratinocytes in S phase, pregnant animals at 
18.5 d of gestation were injected with BrdU. 1 h later, embry-
onic skin was collected and analyzed by immunofl  uorescence 
analysis. BrdU-positive cells resided in the basal cell layer of 
p14
∆ep/+ and p14
∆ep epidermis. The number of BrdU-positive 
cells in the p14
∆ep epidermis was reduced to 54% (Fig. 4, A and C). 
The mitotic index of the epidermis was determined by immuno-
fl  uorescence microscopy with antiphosphohistone H3 antibody. 
Mitotic cells localized to the basal layer of p14
∆ep/+ and p14
∆ep 
epidermis. The number of mitotic cells in the p14
∆ep epidermis 
was reduced to 50% (Fig. 4, B and C). These fi  ndings suggested 
that endosomal p14–MP1-MEK1 signaling regulates prolifera-
tion in the epidermis.
Next, we asked whether the regulation of proliferation 
was a general and cell-autonomous function. Isolated p14
∆ep 
Figure 4.  The p14–MP1 complex regulates cell cycle 
progression and cellular proliferation. (A and B) Fro-
zen skin sections from E18.5 p14
∆ep and p14
∆ep/+ 
embryos were analyzed by confocal immunoﬂ  uores-
cence microscopy and quantiﬁ  cation. Representative 
images are shown. Bars, 10 μm. (A) DAPI is shown in 
blue, and BrdU is shown in red. The dotted white line 
indicates the epidermal–dermal boundary. (B) β4-
  Integrin is shown in red, and phosphohistone H3 is 
shown in green. Note the unspeciﬁ   c background 
  staining in the stratum corneum in panel p14
∆ep/+. 
(C) BrdU-positive cells were quantiﬁ  ed in 25 random 
ﬁ   elds of view from four different embryos. In the 
p14
∆ep/+ epidermis, 22 ± 2.2 (SD [error bars]) cells/
ﬁ  eld of view were BrdU-positive cells. In the p14
∆ep 
epidermis, 12 ± 1.51 (54.5%) were BrdU positive. 
Phosphohistone H3 (pH3)–positive cells were quanti-
ﬁ   ed in 58 random ﬁ   elds of view from six different 
embryos. The mean per ﬁ  eld of view was 10 ± 1.1 
phosphohistone H3–positive cells (100%) in the 
p14
∆ep/+ epidermis and 5 ± 0.57 (50%) in the p14
∆ep 
epidermis. P < 0.001. (D) 0.5 × 10
4 p14
f/−;IRES-
GFP,  p14
−/−;IRES-GFP,  p14
−/−;p14-IRES-GFP, and 
p14
−/−;p14caax-IRES-GFP MEFs were plated. Cells 
were counted at the indicated times. On day 4, p14
f/−;
IRES-GFP had grown to 2.02 × 10
4 MEFs (100 ± 
21%),  p14
−/−;IRES-GFP had grown to 1.10
4 MEFs 
(54.4  ± 8%), p14
−/−;p14-IRES-GFPhad grown to 
2.10
4 MEFs (103 ± 16%), and p14
−/−;p14caax-IRES-GFP had grown to 0.9 × 10
4 MEFs (44.5 ± 22%; n = 3). Growth-arrested MEFs were released 
into S phase. The number of mitotic cells was analyzed by DAPI and phosphohistone H3 staining. Mitotic indexes before the release (t = 0) were as follows: 
p14
f/−;IRES-GFP, 5.2 ± 0.2% (n = 166); p14
−/−;IRES-GFP, 3.8 ± 1.8% (n = 300); p14
−/−;p14-IRES-GFP, 5.2 ± 0.8% (n = 325); and p14
−/−;p14caax-
IRES-GFP, 1.4 ± 0.2% (n = 260). 24 h after the release (t = 24 h), mitotic indexes were as follows: p14
f/−;IRES-GFP, 24 ± 4.5% (n = 122); p14
−/−;IRES-GFP, 
6 ± 1.7% (n = 83); p14
−/−;p14-IRES-GFP, 21 ± 6.6% (n = 109); and p14
−/−;p14caax-IRES-GFP, 3% (n = 42). (E) Quantitative analysis by propidium 
  iodide FACS of the DNA content of p14
f/− and p14
−/− MEFs 6 h after mitogenic stimulation. Results for p14
f/− and p14
−/− MEFs, respectively, were as 
  follows: G1 phase, 42.2 and 70%; S phase, 44.2 and 17.7%; and G2–M phase, 12.8 and 12.2% (n = 3).JCB • VOLUME 175 • NUMBER 6 • 2006  866
  keratinocytes exhibited no or extremely poor growth. Therefore, 
we used MEFs to determine whether p14 regulates proliferation. 
An equal number of p14
f/− and p14
−/− MEFs were plated and 
grown for 3 d. After 3 d, p14
f/− MEFs grew twice as fast com-
pared with p14
−/− MEFs (Fig. 4 D). Importantly, the growth de-
fect in continuously growing cultures was fully restored by the 
retroviral reexpression of wt p14 in p14
−/− MEFs (Fig. 4 D).
To address whether cellular proliferation requires the en-
dosomal localization of p14, we used the p14caax mutant, which 
effi  ciently retargets the p14–MP1 complex from endosomes to 
the plasma membrane (Wunderlich et al., 2001). The p14caax 
mutant could not rescue the growth defect of p14
−/− MEFs (Fig. 
4 D). This indicates that only an endosomal p14–MP1 complex 
provides certain spatial information that is required for cell 
  cycle progression. These fi  ndings substantiated a link between 
endosomal signaling and the regulation of proliferation.
To determine the mitotic index, MEFs were growth ar-
rested by contact inhibition and 48-h serum starvation. MEFs 
were released from the growth arrest by subconfl  uent replat-
ing in either FCS- or EGF-containing medium (EGF data is not 
depicted; results were similar to those from FCS-treated cells). 
After 24 h in FCS, the mitotic p14
f/− MEFs had increased from 
5 to 24%, whereas the number of mitotic p14
−/− MEFs changed 
from 4 to 6% (Fig. 4 D). Expression of the mutant p14caax 
did not restore the defects in mitotic entry (Fig. 4 D) nor did 
the overexpression of MEK1 or MP1 in p14
−/− MEFs (not 
depicted). The reexpression of p14 in p14
−/− MEFs fully restored 
mitogenic proliferation (Fig. 4 D), showing that endosomal 
p14–MP1-MEK1 signaling regulates proliferation in a cell-
autonomous manner. The defects of mitogenic entry were also 
refl  ected by reduced BrdU incorporation after mitogenic stimu-
lation (Fig. S1 F), indicating a delay in S-phase entry. Next, 
we determined how the loss of p14 would affect entry into 
mitosis upon mitogenic stimulation using propidium iodide FACS 
analysis. 6 h after release from the growth arrest into FCS-
  containing medium, 44% of the p14
f/− MEFs had entered S phase. 
In contrast, only 17% of the p14
−/− MEFs had entered S phase, 
and 70% were still in G1 phase (Fig. 4 E).
In conclusion, p14 is the adaptor protein that recruits 
the scaffold protein MP1 to late endosomes. There, MP1 inter-
acts with MEK1, which, in turn, controls the late endosomal 
traffi  c of activated cell surface receptors and endosomal ERK 
acti  vation. This provides the spatial and temporal resolution of 
ERK signaling that is required to promote proliferation in vivo. 
Thus, our fi  ndings indicate that cells coordinate extracellular 
signaling and endosomal traffi  c to regulate proliferation during 
tissue homeostasis.
Materials and methods
Targeting constructs
The HSV-Tk cassette for negative selection and an FRT-NEO-FRT loxP 
cassette were gifts from M. Busslinger (Institute of Molecular Pathology, 
Vienna, Austria). The IRES-hrGFP-SV40polyA cassette was from Vitality 
hrGFP (Stratagene). The genomic locus of p14 was ampliﬁ  ed from HM-1 
(E14.1 derivative) DNA with Herculase (Stratagene). All cassettes and 
the genomic locus for the targeting vector were cloned into pSP64 vector 
with a modiﬁ  ed polylinker. The 5′ loxP site was inserted before exon 1. 
The IRES-driven hrGFP was inserted to follow p14 promoter activity 
upon deletion. The 5-kb-long arm was generated using three PCRs: prim-
ers (all sequences are listed in the supplemental material, available at 
http://www.jcb.org/cgi/content/full/jcb.200607025/DC1) 152–153, 
154–181, and 180–193. The intermediate fragment, the four exons, and 
poly-A was ampliﬁ  ed by PCR using primers 188–194 and was ﬂ  anked 
5′ by a loxP site. The short arm of the targeting vector was generated by 
PCR using the primers 184–185 and cloned 3′ of the FRT-NEO-FRT loxP 
and IRES-hrGFP cassette. Gene targeting was performed in HM-1 (E14.1 
derivative) embryonic stem cells by electroporating the linearized   targeting 
construct. For selection, 300 μg/ml G418 was used, and clones were 
screened by PCR and Southern blot analysis. Chimeric mice were created 
by the injection of two independent targeted embryonic stem cell clones 
into C57BL/6 blastocysts.
PCR genotyping, Southern blots, and Western blots
For genotyping, DNA was extracted from tails according to standard 
  protocols. For genotyping of the epidermis tail, the epidermis was sepa-
rated from dermis by dispase II (Roche) digest, and DNA was extracted 
according to standard protocols. For Southern blots, 10 μg KpnI-digested 
DNA were probed by using a 450-bp external probe (primers 219–220). 
Primer sequences are listed in the supplemental material. Western blots 
were performed as previously described (Teis et al., 2002).
Histology, semithin sections, and immunoﬂ  uorescence
Isolated skin pieces were embedded in optimal cutting temperature–Tissue-
Tek on dry ice. Immunoﬂ  uorescence was performed on 6-μm frozen sec-
tions as previously described (Vasioukhin et al., 2001) and were analyzed 
using a confocal microscope (LSM510 Meta; Carl Zeiss MicroImaging, 
Inc.; for details, see supplemental material). For semithin section micros-
copy, skin was ﬁ  xed with glutaraldehyde (2.5% vol/vol in 0.1 M sodium 
cacodylate buffer, pH 7.4) followed by unbuffered aqueous osmium 
  tetroxide (1% wt/vol) and unbuffered aqueous uranyl acetate (0.5% wt/vol). 
Specimens were embedded in Epon epoxy resin. 500-nm semithin sections 
were stained with Toluidine blue. Immunoﬂ  uorescence on MEFs was per-
formed as previously described (Teis et al., 2002) and was analyzed using 
a microscope (Axioplan2 or confocal LSM510 Meta; Carl Zeiss Micro-
Imaging, Inc.; for details, see supplemental material).
Antibodies and endocytic cargos
Primary antibodies were used according to the manufacturer’s   instructions. 
Anti-ERK1/2, antiphospho-ERK1/2, antiphospho-AKT, antiphospho-MEK1/2, 
antiphospho-p38, and antiphospho-JNK1/2 were purchased from Cell 
Signaling Technology. Antikeratins 1, 6, 10, and 14 were obtained 
from Covance. Anti–β-integrin 4 and anti–mouse Lamp1 antibody were 
  purchased from BD Biosciences. Anti-Ki67 was obtained from Nova-
castra, anti-BrdU was purchased from Roche, and antiphosphohistone 3 
was purchased from Upstate Biotechnology. Anti-EGFR and -EEA1 antibodies 
were obtained from Fitzgerald and Santa Cruz Biotechnology, Inc., and 
anti-LAMP1 was purchased from BD Biosciences. The LBPA antibody was a 
gift from J. Gruenberg (University of Geneva, Geneva, Switzerland). Anti-
p14 and -MP1 antibodies were described previously (Teis et al., 2002). 
Fluorescently labeled secondary antibodies are listed in the supplemental 
materials. MEFs were stimulated with 50 ng/ml AlexaFluor594-transferrin 
or 100 ng/ml of ﬂ  uorescently labeled EGF for 10 and 30 min or were 
incubated with 3 mg/ml AlexaFluor488-dextran for 15 and 45 min.
BrdU labeling
Pregnant animals at day 18.5 of gestation were injected intraperitoneally 
with 1 ml/100 g bodyweight of a 10-mM BrdU (Roche) solution. Embry-
onic skin was removed and embedded in optimal cutting temperature–
Tissue-Tek. Tissue culture cells were incubated for 30 min with 10 μM BrdU. 
Samples were processed according to the manufacturer’s instructions.
Isolation of epidermis
To separate the epidermis from dermis, skin was incubated (dermis facing 
down) in Dispase II (Roche) for 30 min at 32°C. To extract proteins, 
isolated epidermis was incubated in protein lysis buffer (50 mM Tris-HCl, 
200 mM NaCl, 1% Triton X-100, 10% glycerol, 5 mM Na4P2O7, 
2 mM Na3OV4, 50 mM NaF, 20 mM β-glycerophosphate, and protease 
inhibitors) and mechanically disrupted using a mixer mill tissue homoge-
nizer (MM 301; Retsch).
Generation of the p14 knockout cell line and MEF cell culture
MEFs were generated from day 13.5 p14
f/− embryos. p14
f/− MEFs were 
immortalized with E1A retrovirus and were subsequently infected with ENDOSOMAL SCAFFOLD ADAPTOR REGULATES PROLIFERATION • TEIS ET AL. 867
  either a control adenovirus or with an adenovirus-expressing Cre (gift 
from M. Cotten, GPC Biotech, Munich, Germany). Single-cell clones 
were   selected and scored for p14 protein by Western blotting. For experi-
ments involving starvation and mitogenic stimulation, MEFs were grown 
on ﬁ   bronectin-coated dishes (10 μg/ml ﬁ   bronectin). MEFs were growth 
arrested by contact inhibition and 48-h serum starvation. MEFs were released 
from the growth arrest by subconﬂ  uent replating in FCS-containing   medium. 
KSR1
−/− and KSR1
+/+ MEFs were provided by A.S. Shaw (Washington 
University School of Medicine, St. Louis, MO; Nguyen et al., 2002). 
MEK1
−/− and MEK1
+/+ MEFs were gifts from M. Baccarini (University of 
Vienna and Medical University of Vienna, Vienna, Austria; Giroux et al., 
1999; Galabova-Kovacs et al., 2006).
Epidermal barrier assay
Embryos were incubated for 8 h at 37°C in staining solution (1.3 mM 
MgCl2, 100 mM NaPO4, 3 mM K3Fe(CN)6, 3 mM K4Fe(CN)6, and 1 mg/ml 
X-Gal, pH 4.5, with HCl) according to Hardman et al. (1998).
Generation of retrovirus and infection
Mouse p14 and the p14caax cDNAs were subcloned into the retroviral 
transfer vector MMP (Klein et al., 2000). For retroviral gene transfer, em-
bryonic ﬁ  broblasts were transduced at an MOI of 5 in the presence of 
8 μg/ml polybrene (Sigma-Aldrich).
Statistics
The epidermis of at least four different mice for the respective phenotype 
was analyzed by counting positive cells per random ﬁ   eld of view 
(at least 25). The mean was calculated with a SD in a conﬁ  dence inter-
val of P < 0.001. Growth curves of MEFs were evaluated in three inde-
pendent experiments.
Endosome distance analysis
Images of LAMP1 immunoﬂ  uorescence were acquired using a CCD camera 
(AxioCam HRC; Carl Zeiss MicroImaging, Inc.) on an epiﬂ   uorescence 
microscope (Axiovert; Carl Zeiss MicroImaging, Inc.) at 16-bit data depth. 
Image analysis was performed with MATLAB software (The MathWorks) 
using custom-designed scripts. Nuclei were identiﬁ  ed using the DAPI nu-
clear counterstain. The position of the geometric center of the nucleus was 
calculated for each cell and used as a parameter representative of the cell 
center. Individual endosomes were identiﬁ  ed on the basis of their ﬂ  uores-
cence intensities using a local thresholding approach. Endosome distances 
were binned in units of 2 μm in the range of 0 to 40 μm (from the nuclear 
center). The number of endosomes in each bin was used for further   analysis. 
24 p14
f/− (1,804 late endosomes), 20 Mek1
+/+ (3,351 late endosomes), 
and 19 p14
−/− cell (1,795 late endosomes) and 21 Mek1
−/− (3,783) 
MEFs were analyzed. Results are given in relative frequencies   (percentages) 
for each distance. Extreme cells (Fig. S2 B) were excluded from evaluation. 
A chi-square independence test was performed on the original data (sum 
of all endosomes per bin). Endosome distance distributions were found to 
be signiﬁ  cantly different (P < 0.001).
Acquisition and processing of images
An imaging microscope (Axioplan2; Carl Zeiss MicroImaging, Inc.) with a 
100× NA 1.3 oil objective (AxioPlan NeoFluar; Carl Zeiss MicroImaging, 
Inc.) was used for all images shown in Fig. 2 A and Fig. S2 B. For the ac-
quisition of images, a camera (AxioCam HRc; Carl Zeiss MicroImaging, 
Inc.) and AxioVs40V4.5.0.0 software (Carl Zeiss MicroImaging, Inc.) were 
used. All ﬂ   uorochromes (AlexaFluor568 donkey anti–goat IgG [H+L], 
  AlexaFluor568 goat anti–mouse IgG [H+L], and AlexaFluor594 goat anti–
rat IgG [H+L]) used in these two ﬁ  gures were purchased from Invitrogen.
A confocal laser-scanning microscope (LSM510 Meta; Carl Zeiss 
MicroImaging, Inc.) with a 63× plan-Apochromat NA 1.4 oil objective 
(phosphohistone 3; Carl Zeiss MicroImaging, Inc.) was used for all images 
shown in Figs. 1 C, 2 (C and D), 3 (C–E), 4 (A and B), and in Figs. S1 
(G and H) and S2 A. For the acquisition of images, LSM Image Examiner 
software (version 3.1.0.117; Carl Zeiss MicroImaging, Inc.) was used. All 
ﬂ   uorochromes (AlexaFluor488-dextran [mol wt of 10,000 kD; anionic 
  ﬁ  xable], AlexaFluor594-transferrin, AlexaFluor488-streptavidin complexed 
to EGF and biotinylated streptavidin, AlexaFluor488 goat anti–rabbit IgG 
[H+L], AlexaFluor568 goat anti–mouse IgG [H+L], AlexaFluor594 goat 
anti–rat IgG [H+L], AlexaFluor568 donkey anti–goat IgG [H+L], Alexa-
Fluor568 donkey anti–goat IgG [H+L], and AlexaFluor568 donkey anti–
goat IgG [H+L]) used in these ﬁ  gures were purchased from Invitrogen.
All immunoﬂ  uorescence was performed at room temperature. In ad-
dition to the Zeiss software, images have been converted to Photoshop 
(version 9.0; Adobe). Brightness, contrast, or tonal value was improved, 
and ﬁ  gures were arranged with Macromedia Freehand MX 11.0 software 
(Adobe) and exported as jpeg ﬁ  les.
Primer sequences
The following primers were used: 152 (T  G  C  G  G  T  T  T  A  T  T  A  G  T  A  G  T  T  G  T  G  G  T  C  ), 
153 (G  T  G  C  T  A  C  T  G  C  A  T  C  G  A  T  C  C  T  C  T  G  T  A  ), 154 (T  A  C  A  G  A  G  G  A  T  C  G  A-
T  G  G  C  A  G  T  A  G  C  A  C  ), 181 (G  A  A  A  C  G  G  T  T  G  T  G  T  A  G  T  T  C  A  G  T  ), 180 (G  T  G-
C  A  A  T  T  C  T  G  G  A  G  C  A  G  C  T  T  C  ), 193 (A  G  C  C  T  C  T  T  G  C  T  C  T  C  C  C  T  C  A  G  T  ), 
188 (G  G  G  C  A  C  T  G  G  G  C  A  G  C  C  C  T  G  C  C  A  ), 194 (G  C  G  A  C  T  G  T  A  G  G  G-
G  T  G  T  G  T  T  G  G  ), 184 (G  G  C  T  T  C  T  C  C  A  G  T  G  C  T  G  T  G  T  C  T  ), 185 (A  G  A  C-
C  T  G  C  A  C  C  T  G  G  C  T  C  C  T  C  T  ), 215 (G  G  T  G  A  C  T  A  C  A  A  C  T  C  C  C  A  G  G  C  G  ), 
202 (C  A  A  G  G  G  C  A  T  G  C  A  T  A  G  A  T  G  ), 218 (G  A  G  T  G  G  T  T  T  C  C  T  C  G  G  G  A-
G  G  A  T  ), 208 (A  A  T  G  G  C  C  T  C  A  A  C  T  C  T  C  A  G  C  T  T  ), 170 (A  G  C  T  G  G  T  T  G  C-
C  G  A  A  C  A  G  G  A  T  G  ), 219 (T  G  C  A  C  A  T  G  C  A  T  C  C  T  G  C  C  T  G  C  T  ), and 220 
(C  T  C  A  T  G  G  C  A  G  G  C  A  G  G  T  G  A  C  T  A  ).
Online supplemental material
The supplemental material contains a description and characterization 
of the conditional p14 allele, marker analysis of the p14-deﬁ  cient epi-
dermis, and a characterization of ﬂ  uid phase endocytosis and recycling of 
transferrin in p14- and MEK1-deﬁ   cient MEFs. Fig. S1 shows the target-
ing strategy, PCR genotyping, and Southern and Western blotting as well 
as differentiation and apoptosis markers in the epidermis. Fig. S2 shows 
that p14 is not required for transferrin receptor recycling and ﬂ  uid phase 
endocytosis but is required for late endosomal positioning and EGFR 
  de  gradation. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200607025/DC1.
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